Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators

Details for Australian Patent Application No. 2002342318 (hide)

Owner ORTHO-MCNEIL PHARMACEUTICAL CORPORATION

Inventors Reitz, Allen B; Zhao, Boyu; Plata-Salaman, Carlos; Smith-Swintosky, Virginia L; Pan, Kevin; Fitzpatrick, Louis J; Eisinger, Magdalena; Lee, Daniel H

Agent Shelston IP

Pub. Number AU-A-2002342318

PCT Number PCT/US02/35340

PCT Pub. Number WO2003/040117

Priority 60/337,927 08.11.01 US

Filing date 4 November 2002

Wipo publication date 19 May 2003

International Classifications

C07D 285/08 Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/433 - Thiadiazoles

A61P 003/00 Drugs for disorders of the metabolism

A61P 017/00 Drugs for dermatological disorders

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/337,927 08.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002342318

3 June 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from OrthoMcNeil Pharmaceutical Corporation to Ortho-McNeil Pharmaceutical, Inc

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002342319-Complexes for transferring substances if interest into a cell

2002342317-Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes